The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats

Microvascular Research

Volumn 59, Issue 2, 2000, Pages 243-254

  Rakusan, Karel ^a   Cicutti, Nicholas ^a   Maurin, Anne ^b   Guez, David ^c   Schiavi, Pierre ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CERB   (France)

^c IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Angiogenesis; Arterioles; Capillaries; Hypertension; RAS

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INDAPAMIDE; LOSARTAN; PERINDOPRIL; RAMIPRIL; SPIRAPRIL; ZABICIPRIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; HISTOPATHOLOGY; HYPERTENSION; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE;

ANIMALIA;

EID: 0034109905     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1999.2224     Document Type: Article

References (35)

1. Anversa P., Capasso J. M. Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. Am. J. Physiol. 260:1991;H1552-H1560.
2. Bataillard A., Schiavi P., Sassard J. Pharmacological properties of indapamide: Rationale for use in hypertension. Clin. Pharmacokinet. 37:1999;7-12.
3. Bock P. The arterial length-densities under preventive angiotensin-converting enzyme inhibiting treatment in the myocardium of spontaneously hypertensive rats. Basic Res. Cardiol. 93:1998;18-22.
4. Canby C. A., Tomanek R. J. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy. Am. J. Physiol. 257:1989;H1110-H1118.
5. Castaigne A., Chalmers J., Morgan T., Chastang C., Feldmann L., Guez D. Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination: A randomized, double blind, placebo-controlled study in elderly patients with mild to moderate hypertension. Clin. Exp. Hypertens. 21:1999;1097-1110.
6. Chen Y., Torry R. J., Baumbach G. L., Tomanek R. J. Proportional arteriolar growth accompanies hypertrophy induced by volume overload. Am. J. Physiol. 267:1994;H2132-H2137.
7. Chrysant S. G. Vascular remodeling: The role of angiotensin-converting enzyme inhibitors. Am. Heart J. 135:1998;S21-S30.
8. Clozel J. P., Kuhn H., Hefti F. Effect of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J. Hypertens. 7:1989;267-275.
9. Fan T.-P. D., Hu D. E. Losartan (DuP 753) blocks the angiogenic effect of angiotensin II in rats. FASEB J. 6:1992;A957.
10. Fernandez L. A., Twickler J., Mead A. Neovascularization produced by angiotensin II. J. Lab. Clin. Med. 105:1985;141-145.
11. Gibbons G. H., Dzau V. J. The emerging concept of vascular remodeling. N. Eng. J. Med. 330:1994;1431-1438.
12. 2 receptors prevents the increases in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 29:1997;478-482.
13. Hansson L. Rationale for combination therapy. Br. J. Clin. Pharmacol. 23:1987;15S-19S.
14. Hernandez I., Cowley A., W. J. R., Lombard J. H., Greene A. S. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am. J. Physiol. 263:1992;H664-H667.
15. Heron M. I., Rakusan K. Short- and long-term effects of neonatal hypo- and hyperthyroidism on coronary arterioles in rats. Am. J. Physiol. 271:1996;H1746-H1754.
16. LeNoble F. A. C., Hekking J. W. M., Van Straaten H. V. M., Slaaf D. W., Stuijker-Boudier H. A. J. Angiotensin II stimulated angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol. 195:1991;305-306.
17. LeNoble F. A. C., Kessels-van Wylick C. G. A., Hacking W. J. G., Slaaf D. W., Egbring M. C. A. O., Struijker-Boudier H. A. J. The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J. Vasc. Res. 33:1996;480-488.
18. Levy B., Poitevin P., Duriez M., Guez D., Schiavi P., Safar M. Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats. J. Hypertens. 15:1997;251-258.
19. Linz W., Jessen T., Becker R. H., Scholkens B. A., Wiemer G. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation. 96:1997;3164-3172.
20. Liu Y.-H., Yang X.-P., Sharov V. G., Nass O., Sabbah H. N., Peterson E., Carretero O. A. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptors antagonists in rats with heart failure. J. Clin. Invest. 99:1997;1926-1935.
21. Olivetti G., Cigola E., Lagrasta C., Ricci R., Quaini F., Monopoli A., Ongini E. Spirapril prevents left ventricular hypertrophy, decreases myocardial damage and promotes angiogenesis in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 21:1993;362-370.
22. Rakusan K. Microcirculation in the stressed heart. Legato M. J. The Stressed Heart. 1987;107-124 Nijhoff, Boston.
23. Rakusan K., Cicutti N., Kazda S., Turek Z. Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats. Hypertension. 24:1994;205-211.
24. Rakusan, K.1999. Vascularization of the heart during normal and pathological growth. InCoronary Angiogenesis (K. Rakusan, Ed.), pp. 129-154, JAI Press, Stamford, CT.
25. Richard V., Joannides R., Henry J. P., Mulder P., Mace B., Guez D., Schiavi P., Thuillez C. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: Haemodynamic, biological and structural effects. J. Hypertens. 14:1996;1447-1454.
26. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler. Thromb. Vasc. Biol. 17:1997;257-264.
27. Sabri A., Samuel J.-L., Marotte F., Poitevin P., Rappaport L., Levy B. I. Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. Hypertension. 32:1998;371-375.
28. Schieffer B., Wirger A., Meybrunn M., Seitz S., Holtz J., Riede U. N., Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after mycardial infarction in the rat. Circulation. 89:1994;2273-2282.
29. 1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc. Res. 31:1996;568-576.
30. Stoll M., Meffert S., Stroth U., Unger T. Growth or antigrowth: Angiotensin and the endothelium. J. Hypertens. 13:1995;1529-1534.
31. Stuijker-Boudier A. J., LeNoble J. L. M. L., Messing M. W. N., Huijbberts M. S. P., LeNoble F. A. C. The microcirculation and hypertension. J. Hypertens. 10:1992;S147-S156.
32. Tornig J., Amann K., Ritz E., Nichols C., Zieler M., Mall G. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of perindopril, nifedipine and monoxidine. J. Am. Soc. Nephrol. 7:1996;667-675.
33. Towsend R. R., Holland O. B. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch. Intern. Med. 150:1990;201-211.
34. Unger T., Mattfeldt T., Lamberty V., Bock P., Mall G., Linz W. I., Scholkens B. W., Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension. 20:1992;478-482.
35. Vicaut E. Hypertension and the microcirculation: A brief overview of experimental studies. J. Hypertens. 234:1992;S59-S68.